当前位置: Nature » 免疫学 » 正文


摘要 : 临床应用中的大部分抗生素都是通过筛选可培养的土壤微生物发现的,这是一个在很大程度上已经耗尽、没有通过合成方法得到充分替代的资源。因此,对于抗生素抗药性之扩散的担心普遍存在。




Kim Lewis 及同事利用最近建立的一个系统对以前未培养的土壤细菌进行原位培养,识别出一种β-变形杆菌 “Eleftheria terrae sp.”,它能产生一种他们称之为 “teixobactin”的酯肽。Teixobactin在活体中有活性,分别以细菌细胞壁中两大主要成分“肽聚糖”和“磷壁酸”其中之一的生物合成通道中的前体为作用目标。

寻找对 teixobactin有抵抗力的突变体的筛选工作结果是阴性的,这也许是由这种新颖的双目标作用机制造成的。


A new antibiotic kills pathogens without detectable resistance

Antibiotic resistance is spreading faster than the introduction of new compounds into clinical practice, causing a public health crisis. Most antibiotics were produced by screening soil microorganisms, but this limited resource of cultivable bacteria was overmined by the 1960s. Synthetic approaches to produce antibiotics have been unable to replac this platform. Uncultured bacteria make up approximately 99% of all species in external environments, and are an untapped source of new antibiotics. We developed several methods to grow uncultured organisms by cultivation in situ or by using specific growth factors. Here we report a new antibiotic that we term teixobactin, discovered in a screen of uncultured bacteria. Teixobactin inhibits cell wall synthesis by binding to a highly conserved motif of lipid II (precursor of peptidoglycan) and lipid III (precursor of cell wall teichoic acid). We did not obtain any mutants of Staphylococcus aureus or Mycobacterium tuberculosis resistant to teixobactin. The properties of this compound suggest a path towards developing antibiotics that are likely to avoid development of resistance.(doi:10.1038/nature14098)

Antibiotics: An irresistible newcomer

A screen of 10,000 bacterial strains, cultured in their normal soil, has uncovered an antibiotic with broad and potent activity. And because the compound targets lipid molecules, developing resistance is probably difficult. (doi:10.1038/nature14193)

对应Nature杂志: 2015年01月22日Nature杂志精选

来源: Nature 浏览次数:303


RSS订阅 - 填写您的邮件地址,订阅我们的精彩内容: - 网站地图
网站联系电话:020-87540820 备案号:粤ICP备11050685号-8 增值电信业务经营许可证:粤B2-20120479
©2011-2015 生物帮 All rights reserved.